Sign in to view content

Modeling the Effect of Longer-Acting Drugs and Reimbursement Changes

Robert A Diamond, BBA

Video
Published 2022

Related

Impact of Delayed Treatment in Diabetic Retinal Disease: Experience From VISTA/VIVID and PANORAMA
Sunil Srivastava, MD
Annual Meeting Talks
2021
Results of Perimetry at Age of 10 Years in Severe ROP Eyes Receiving Laser or Anti-VEGF Treatment as Primary Monotherapy
Alay S. Banker, MD
Annual Meeting Talks
2020
Subthreshold Micropulse Yellow Laser Photocoagulation in Macular Edema Refractory to Anti-VEGF Treatment in Case of BRVO
MATTEO M FORLINI, MD
On Demand Cases, Courses, and Papers
2019

Category: Practice Management

Anti VEGF

See more